Researcher discovers mechanism to slow tumor growth and metastasis in breast cancer

July 9, 2013 by Cindy Young

(Medical Xpress)—Wright State University Boonshoft School of Medicine professor Julian Gomez-Cambronero, Ph.D., and his research team have discovered a key protein that plays a critical role in the development of breast cancer tumors and the spread of the disease to the nearby lungs.

Cambronero's findings, published this month in the leading cancer journal Oncogene (click here for the report), attribute the cancer's growth to a protein called Phospholipase D (PLD). Cambronero and his team found that by introducing two new of PLD they could shrink tumor growth and reduce subsequent metastasis by around 70 percent.

"Although it's still early to tell, the application of these inhibitors to research in human tissue is the next step that could lead to better, less toxic treatments in the battle against ," said Cambronero, a professor of biochemistry and molecular biology.

Breast cancer kills more women in the United States each year—about 40,000—than any other type of cancer, according to the National Cancer Institute. The disease strikes an estimated 232,340 females each year and 2,240 males.

Explore further: Discovering a new role for a breast cancer gene

Related Stories

Study finds new drug target for metastatic breast cancer

April 11, 2013

Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the ...

Developmental protein plays role in spread of cancer

June 14, 2013

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers at the ...

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.